Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit
| RVPH Stock | USD 1.91 0.02 1.06% |
Under 55% of Reviva Pharmaceuticals' traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Reviva Pharmaceuticals Holdings suggests that some traders are interested. Reviva Pharmaceuticals' investing sentiment shows overall attitude of investors towards Reviva Pharmaceuticals Holdings.
Reviva |
CUPERTINO, Calif., Jan. 07, 2025 -- Reviva Pharmaceuticals Holdings, Inc. , a late-stage pharmaceu
Read at gurufocus.com
 |
Reviva Pharmaceuticals Fundamental Analysis
We analyze Reviva Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reviva Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reviva Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Reviva Pharmaceuticals is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Reviva Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reviva Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reviva Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reviva Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Reviva Pharmaceuticals Related Equities
| LTRN | Lantern Pharma | 29.50 | ||||
| CUE | Cue Biopharma | 14.88 | ||||
| ZVSA | ZyVersa Therapeutics | 7.86 | ||||
| SLS | Sellas Life | 2.02 | ||||
| ATHA | Athira Pharma | 1.82 | ||||
| FBIO | Fortress Biotech | 0.55 | ||||
| ACAD | ACADIA Pharmaceuticals | 2.15 | ||||
| PLX | Protalix Biotherapeutics | 2.77 | ||||
| EYPT | Eyepoint Pharmaceuticals | 3.29 | ||||
| INAB | In8bio | 3.45 | ||||
| CABA | Cabaletta Bio | 3.47 | ||||
| UNCY | Unicycive Therapeutics | 4.76 |
Complementary Tools for Reviva Stock analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |